Re: Conflicting asthma guidelines cause confusion in primary care

Source: BMJ Comments - Category: General Medicine Source Type: forums

Related Links:

ConclusionsA history of asthma or sinonasal disease may modulate immunological response to reduce incidence of active TB in the adult population.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 18 August 2018Source: Saudi Journal of Biological SciencesAuthor(s): Shufen Zhu, pengfei Li, hong Suo, jingsheng Dong, liying CuiAbstractPolymorphisms in the gene encoding for A disintegrin and metalloprotease 33 (ADAM33) are closely associated with the risk of bronchial asthma attacks in different populations. We collected blood samples from 248 asthma patients - 130 of the Han ethnic group and 118 of the Mongolian ethnic group - living in the Inner Mongolia region of China, and analyzed the single nuclear polymorphisms (SNPs) of the T1, T2 and V4 loci of the ADAM33 gene using ...
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
ASTHMA symptoms include wheezing, difficulty breathing and having a tight chest. But, you should also never ignore having an itch in this unusual place. These are the deadly lung condition ’s signs to watch out for.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Disclosed are (N)-methanocarba adenine nucleosides, e.g., of the formula (I): as A3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein A, a, R2, and R3 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. Also disclosed are conjugates comprising a dendrimer and one or more ligands, which are functionalized congeners of an agonist or antagonist of a receptor of the G-protein couple...
Source: NIDDK Research Resources - Category: Endocrinology Source Type: research
The five Muscarinic Acetylcholine (ACh) receptors are G-protein coupled receptors (M1R-M5R). M1R, M3R and M5R selectively couple to Gq/G11; M2R and M4R selectively couple to Gi/Go. M3 muscarinic ACh receptors are present in the central nervous system and the periphery.M3R knockout mice are viable and fertile, and have no major morphological abnormalities. They have a lean phenotype. This results from a combination of reduced caloric intake and increased energy expenditure. They eat less food than wild-type mice, possibly because a central cholinergic pathway that stimulates food intake is disrupted. They also expend more e...
Source: NIDDK Research Resources - Category: Endocrinology Source Type: research
Conclusions: While the number of identified studies was not large, none reported negative impacts of mHealth on selected outcomes. Future studies on mHealth should design interventions with a greater variety of targeted functions and should adopt more rigorous methodologies to strengthen the evidence for its effectiveness in chronic disease management. PMID: 30109152 [PubMed]
Source: Healthcare Informatics Research - Category: Information Technology Tags: Healthc Inform Res Source Type: research
Conditions:   Asthma;   Cough Intervention:   Device: The patient will undergo no intervention Sponsors:   Cantonal Hospital of St. Gallen;   Claudia Steurer-Stey;   Peter Tinschert;   Tobias Kowatsch;   Filipe Barata;   Florent Baty;   Martin Brutsche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
A fourth biologic for severe eosinophilic asthma may soon be available. Who is a candidate for this therapy and what effects can you expect?Medscape Pulmonary Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news
Conditions:   Asthma;   Cough Intervention:   Device: The patient will undergo no intervention Sponsors:   Cantonal Hospital of St. Gallen;   Claudia Steurer-Stey;   Peter Tinschert;   Tobias Kowatsch;   Filipe Barata;   Florent Baty;   Martin Brutsche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(CNN) — The US Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children. The company Teva Pharmaceuticals gained approval to market the new generic drug, according to an announcement from the FDA on Thursday. Brendan O’Grady, executive vice president who heads North America Commercial at Teva, noted in an emailed statement Thursday that the approval “marks an important step forward in bringing our patients additional prescription medications that have met the FDA’s rigorous standards.&rdqu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News EpiPen generic epipen Local TV Source Type: news
More News: Asthma | General Medicine | Primary Care